Author : Yifei Zhong
Publisher :
Page : pages
File Size : 27,86 MB
Release : 2014
Category :
ISBN :
"The incidence and prevalence of inflammatory bowel diseases (IBD) have dramatically risen in both developed and developing nations in the last 50 years. While there has been much debate on both the genetic and environmental causes of IBD, it is thought to arise from an abnormal immune response to the commensal intestinal microbiota in susceptible individuals. Recent human and mouse genetic results, as well as functional data from experimental animal models of colitis, have both pointed to a key role of the inflammasome-IL-18 pathway in intestinal homeostasis. The inflammasomes are sensors of microbial/danger signals and are key effectors of the innate inflammatory response. They are scaffolded by intracellular pattern recognition receptors and are required for the activation of caspase-1, an inflammatory protease necessary for the processing of IL-1[beta] and IL-18 into their mature biologically active cytokine forms. We hypothesized that IL-18 is required for the activation and effector functions of specific intestinal cells that initiate downstream epithelial repair and host defense mechanisms. In an experimental model of infectious colitis using Citrobacter rodentium infection, we determined that Il18-/- mice were more susceptible to C. rodentium infection compared to wild-type (WT) mice. However, infections using Rag1-/- and Rag1-/-/Il18-/- mice showed a reverse phenotype; Rag1-/- mice showed increased disease phenotypes compared to Rag1-/-/Il18-/- mice. Bone marrow chimera experiments using WT and Il18r-/- mice further demonstrated that IL-18 signaling in the stromal or radio-resistant compartment is vital for host resistance. Altogether, these results suggest that IL-18 plays a dual role in both the innate and adaptive immune responses during an infection that is crucial to control the severity of the disease. The future identification of IL-18-responsive stromal cells as well as the exploration of the role of IL-18 signaling and downstream effector functions of target cells in intestinal homeostasis will further allow us to assemble a more comprehensive picture of interactions between IL-18 and mucosal stromal cells after injury or infection, and how these pathways are able to affect both the generation and progression of the disease." --